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ABSTRACT
Representatives (n = 31) of outbreak strains of Acinetobacter baumannii from five countries fell into three
clear groups, designated Groups 1–3, based on their ompA (outer-membrane protein A), csuE (part of a
pilus assembly system required for biofilm formation) and blaOXA-51-like (the intrinsic carbapenemase
gene in A. baumannii) gene sequences. With the exception of the closely related alleles within the Group
1 clonal complex, alleles at each locus were highly distinct from each other, with a minimum of 14
nucleotide differences between any two alleles. Isolates within a group shared the same combination of
alleles at the three loci, providing compelling evidence that the outbreak strains investigated belonged to
three clonal lineages. These corresponded to the previously identified European clones I–III. Sequence
differences among the alleles were used to design multiplex PCRs to rapidly assign isolates belonging to
particular genotypes to sequence groups. In the UK, genotypes belonging to the Group 1 clonal complex
have been particularly successful, accounting for the vast majority of isolates referred from hospitals
experiencing problems with Acinetobacter.
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INTRODUCTION
Acinetobacter baumannii has emerged globally as
an increasingly important nosocomial pathogen.
It particularly affects patients in intensive care
and burns units, and is usually resistant to most
available antibiotics. Carbapenems have been the
antibiotics of choice for treatment of infections
caused by this organism, but resistance to carb-
apenems is becoming common, and very few
therapeutic options remain. There have been
reports of the increased prevalence of this organ-
ism in hospitals in many countries, including the
UK [1,2], France [3], Spain [4,5], Portugal [6], Italy
[7], Greece [8–10], Israel [11], Bulgaria [12], the
USA [13,14] and Russia [15], with outbreaks often
occurring in multiple hospitals. Many of the
genotypes involved have been found to belong
to pan-European clones (lineages) I, II or III, as
defined by amplified fragment length polymorph-
ism analysis [16,17].
During recent years, hospitals in the UK have
experienced numerous outbreaks caused by wide-
spread genotypes of A. baumannii. In particular,
the genotypes known as the South-east clone and
the OXA-23 clone 1 [1,2] have affected over 40
hospitals each and have persisted for a number of
years, and since at least 2000 in the case of the
South-east clone. In addition, in one hospital, a
further genotype, known as the T strain, which
was associated originally with military casualties
returning from Iraq [18], caused continuing prob-
lems for >2 years. More recently, problems with a
further genotype, referred to as the North-west
strain, have been associated with several hospitals
in northern England and the Midlands. These
highly successful strains represent a new problem
in the UK, with infections and colonisations by
particular genotypes not having been observed
previously on this scale.
Corresponding author and reprint requests: J. Turton, Labor-
atory of HealthCare Associated Infection, Centre for Infections,
Health Protection Agency, 61 Colindale Avenue, London NW9
5EQ, UK
E-mail: jane.turton@hpa.org.uk
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases
A better understanding of how these organ-
isms emerge and spread is urgently required.
The genotypes mentioned above were defined by
pulsed-field gel electrophoresis (PFGE) of ApaI-
digested genomic DNA. However, it is clear that
the alternative approach of sequence-based typ-
ing offers a number of advantages, and can
provide important insights into population struc-
tures. A multilocus sequence typing scheme,
based on housekeeping genes, has been des-
cribed for A. baumannii, and has been reported to
give results that are comparable to those provi-
ded by PFGE [19]. To provide further informa-
tion concerning the UK isolates, the present
study chose to examine sequence variation with-
in three genes likely to be under selective
pressure. This approach has been used previ-
ously for Legionella pneumophila, in which context
it has proved highly useful for outbreak inves-
tigations [20]. Since higher numbers of polymor-
phisms are seen, such an approach has the
potential for greater discrimination than schemes
based on housekeeping genes [20,21], and has
the added advantage that it can provide inform-
ation relevant to pathogenicity.
The genes investigated in the present study
were ompA, csuE and blaOXA-51-like. Outer-mem-
brane protein A (encoded by ompA) is a porin [22],
and has also been found to induce apoptosis of
epithelial cells [23]. The csuE gene codes for part
of a pilus assembly system, thought to be essential
for biofilm formation [24]. The blaOXA-51-like gene
codes for the intrinsic carbapenemase found in
A. baumannii [25,26], although clinically signifi-
cant resistance to carbapenems mediated by
blaOXA-51-like has been observed only in isolates
with the insertion sequence ISAba1 located imme-
diately upstream of the gene; minor sequence
differences are also seen between susceptible and
resistant isolates [27].
The present study began by comparing the
gene sequences of representatives of outbreak
strains from the UK, both within and among
types defined by PFGE. The study was then
extended to include outbreak strains from Spain,
France, Israel and The Netherlands, including
some known to belong to European clones I–III.
These isolates were therefore separated by dis-
tance and, in some cases, by a considerable period
of time. A number of genotypes defined by PFGE
were represented, including some, e.g., OXA-23
clone 1, and the French AYE VEB-1 strain, that
were widespread in the country of origin and had
affected numerous hospitals, as well as others that
were not so prevalent. The findings provide
important information on the population struc-
ture of these organisms, which is central to any
understanding of their epidemiology.
MATERIALS AND METHODS
Isolates
The panel of 34 isolates included representatives of all
outbreak strains of A. baumannii identified from UK hospitals
by the Laboratory of HealthCare Associated Infection, Health
Protection Agency, London, UK during recent years and three
sporadic strains. Where multiple representatives of a genotype
were included, these were, where possible, selected from
different hospitals, and isolated some time apart (between 2002
and 2006). Sporadic isolates (NW1, L4, IR1) had unique PFGE
profiles, and were PCR-negative for the class 1 integrase gene
[28]. Isolate designations, according to hospital (1–32) and
patient (A–J), correspond to those used in previous studies
[2,27,28]. Isolates new to this study, i.e., SE6, SW1, L5A and
L5B (isolated during 2006) and NW1, L4 and IR1 (sporadic
strains isolated between 2003 and 2006), are labelled according
to hospital region (SE, south-east England; L, London; SW,
south-west England; M, Midlands; NW, north-west England;
IR, Ireland), the particular hospital within each region (1–6),
and the patient (A–B). The panel also included representatives
of European clones I (RUH 875, RUH 2034) and II (RUH 134)
isolated between 1982 and 1986, and of European clone III
(RUH 5875) from outbreaks in The Netherlands [16,17,29,30].
Isolates from Spain were representatives of two outbreak
strains (designated clones I and II) identified in a hospital in
northern Spain [5], and those from Israel were representatives
of four outbreak strains (designated A, B, F and H) identified
in a tertiary-care hospital. The AYE VEB-1 strain has affected
multiple hospitals in France [3]. Identification of all isolates as
A. baumannii was confirmed by detection of blaOXA-51-like [26].
Multiplex PCR to detect other OXA carbapenemase genes was
performed as described previously [26,31]. Detection of ISAba1
adjacent to blaOXA-51-like was performed using primers ISAba1F
and OXA-51-likeR as described previously [27].
PFGE and sequence-based typing
PFGE of ApaI-digested genomic DNA was performed as
described previously [2]. Primers for amplifying and sequenc-
ing ompA, csuE and blaOXA-51-like gene fragments are listed in
Table 1. Primers for ompA and csuE were designed from
sequences available at GenBank (AY485227, DQ093960;
AY241696) or from sequences determined during initial
studies (DQ289014–DQ289019). These were aligned and con-
sensus primers were designed from common sequence areas.
Amplicons were made using the primers in Table 1 that gave
the 966-bp (ompA), 976-bp (csuE) or 825-bp (blaOXA-51-like)
products, and sequencing was performed using both these and
the internal primers. Some isolates (notably sporadic isolates)
failed to give the larger csuE (e.g., NW1) or blaOXA-51-like (IR1)
amplicons, and the internal primers were therefore used to
amplify the smaller fragment. PCRs were performed in 25-lL
volumes containing 3 lL of extracted DNA, 10 pmol of each
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primer and 1.5 U of Taq DNA polymerase in 1 · PCR buffer
containing 1.5 mM MgCl2 (Qiagen, Crawley, UK) and 200 lM
each dNTP. Extracted DNA was prepared by suspending 2–3
colonies in 100 lL of tissue culture water, vortexing for 10 s,
and then centrifuging at 10 000 g for 2 min. Standard PCR
conditions were used in combination with the annealing
temperatures listed in Table 1 for each set of primers. For
example, to amplify the 966-bp ompA fragment, PCR condi-
tions were 94C for 3 min, followed by 35 cycles of 94C for
45 s, 50C for 45 s and 72C for 1 min, followed by a final
extension at 72C for 5 min. PCR products were initially
checked by agarose gel electrophoresis and were then purified
using Qiaquick purification columns (Qiagen) according to
the manufacturer’s instructions. The products were then
sequenced using a Beckman Coulter CEQ Dye Terminator
Cycle Sequencer with a Quick Start kit and a CEQ8000
sequencer (Beckman). Sequences were analysed and aligned
using GeneBuilder software (Applied Maths, Sint-Martens-
Latem, Belgium) and compared with sequences available at
GenBank using BLAST searches (http://www.ncbi.nlm.nih.
gov/BLAST/).
Analysis of PFGE and sequence data
Dendrograms showing percentage similarity were prepared
using BioNumerics software (Applied Maths) and the
unweighted pair-group method with arithmetic averages
(UPGMA) for clustering. PFGE profiles were compared using
the Dice coefficient and sequences were compared by pairwise
alignment.
Multiplex PCRs for identification of sequence type groups
Multiplex PCRs for identification of the ompA, csuE and
blaOXA-51-like sequence groups defined as Group 1 and Group 2
(see Results) were performed using the primers listed in
Table 2. These primers were designed from a comparison of
Group 1 and Group 2 sequences at the three loci from
GenBank accession numbers DQ648278, DQ648279,
DQ289014–DQ289019, AY750909, AY750911, DQ309276 and
DQ309277. Reagent concentrations and PCR conditions were
essentially the same as those used for a multiplex OXA
carbapenemase gene ⁄ class 1 integrase gene PCR [26], except
that only 30 cycles were used and the final concentration of
each primer was 400 nM (10 pmol ⁄ 25-lL reaction). PCR
conditions were 94C for 3 min, followed by 30 cycles of
94C for 45 s, 57C for 45 s and 72C for 1 min, followed by a
final extension at 72C for 5 min. The temperature of the
heated lid of the thermocycler was 105C. Identification of a
strain as a member of Group 1 or Group 2 required the
amplification of all three fragments in the corresponding
multiplex PCR, and an absence of any amplification by the
other multiplex PCR. Group 3 isolates were defined by the
amplification of only the ompA fragment in the Group 2 PCR,
and the amplification of only the csuE and blaOXA-51-like
fragments in the Group 1 PCR.
Nucleotide accession numbers
Sequences were deposited at GenBank under accession num-
bers DQ648278, DQ648279, DQ779966, DQ779967 (ompA),
DQ289014–DQ289019, DQ789570–DQ789572 (csuE), and
DQ309276 and DQ309277 (blaOXA-83 and blaOXA-84). These
sequences are longer than the alleles described in this study
(Tables 1 and 3).
Table 1. Sequences of primers used for sequence-based typing
Target Primer sequences
Annealing
temperature
(C)
Amplicon
size (bp) Reference Sequence compared
ompA OmpAF183, 5¢-CAATTGTTATCTCTGGAG-3¢
OmpAR1149, 5¢-ACCTTGAGTAGACAAACGA-3¢
Internal primers (sequencing):
OmpAF506, 5¢-TCAACGGTAACTTCTATG-3¢
OmpAR895, 5¢-CTTCAGTTAACTCTTGTGG-3¢
50 966 This study 686 bp corresponding to nucleotides
39–724 of DQ648278 (alleles variable
in length)a
csuE CsuEF, 5¢-ATGCATGTTCTCTGGACTGATGTTGAC-3¢
CsuER, 5¢-CGACTTGTACCGTGACCGTATCTTGATAAG-3¢
Internal primers:
65 976 This study 449 bp corresponding to nucleotides
230–678 of DQ289018;
5449–5897 of AY241696
CsuEconsensusF, 5¢-AGACATGAGTAGCTTTACG-3¢
CsuEconsensusR, 5¢-CTTCCCCATCGGTCATTC-3¢
52 515
blaOXA-51-like 5¢OXA-51-like-all F, 5¢-ATGAACATTAAAGCACTC-3¢
3¢OXA-51-like-all R, 5¢-CTATAAAATACCTAATTGTTC-3¢
46 825 [27] 693 bp corresponding to nucleotides
79–771 of AJ309734
Internal primers:
OXA-51-likeF, 5¢-TAATGCTTTGATCGGCCTTG-3¢
OXA-51-likeR, 5¢-TGGATTGCACTTCATCTTGG-3¢
60 353 [31]
aSee Table 3.
Table 2. Primers used in the multiplex PCRs for identifi-
cation of sequence type groups
Primer Sequence (5¢ to 3¢) Amplicon size (bp)
Group1ompAF306 GATGGCGTAAATCGTGGTA
Group1and2ompAR660 CAACTTTAGCGATTTCTGG 355
Group1csuEF CTTTAGCAAACATGACCTACC
Group1csuER TACACCCGGGTTAATCGT 702
Gp1OXA66F89 GCGCTTCAAAATCTGATGTA
Gp1OXA66R647 GCGTATATTTTGTTTCCATTC 559
Primer Sequence (5¢ to 3¢) Amplicon size (bp)
Group2ompAF378 GACCTTTCTTATCACAACGA
Group1and2ompAR660 CAACTTTAGCGATTTCTGG 343
Group2csuEF GGCGAACATGACCTATTT
Group2csuER CTTCATGGCTCGTTGGTT 580
Gp2OXA69F169 CATCAAGGTCAAACTCAA
Gp2OXA69R330 TAGCCTTTTTTCCCCATC 162
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RESULTS
PFGE and sequence-based typing
PFGE profiles, together with the allele designa-
tions at each locus, are shown for all strains in
Fig. 1. The sequences corresponding to the allele
designations are listed in Table 3. Alleles 1a, 1a*
and 1b differed from allele 1 by only one or
two nucleotides. Such differences were minor
compared to the more extensive differences
revealed between alleles 1, 2, 3, 4, 5 or 6 at each
locus (Fig. 2). Sequence-based typing divided the
isolates into three distinct groups (designated
Groups 1–3), with isolates within a group all
sharing the same combination of alleles at the
three loci (albeit with some diversity in the Group
1 alleles). All 31 representatives of outbreak
strains investigated, from all five countries,
belonged to one of these three groups. The strains
also clustered into these three groups by PFGE,
but with a similarity of only 69% with the
parameters used in the present analysis.
Sporadic isolates had further, distinct alleles
and ⁄ or unique combinations of alleles at the three
loci. Genotypes of all three groups were associ-
ated with additional OXA carbapenemase genes,
i.e., OXA-23 clone 1 (Group 1), OXA-23 clone 2
and BUAC-1 (Group 2) with blaOXA-23-like genes;
North-west (NW) strain and Israel strain B
(Group 1) with blaOXA-58-like genes; and Israel
strain A (Group 1) and Spanish clones I (Group 3)
and II (Group 1) with blaOXA-24-like (blaOXA-40 or
blaOXA-40-like) genes. The sporadic isolate L4 was
also PCR-positive for a blaOXA-23-like gene.
The number of sequence differences among
alleles associated with the different groups at each
locus was substantial (Fig. 2), and much greater
than those observed between pairs of alleles of
housekeeping genes [19]. For example, individual
csuE alleles differed from one another by up to
5%, with alleles 1 and 2 having 24 base differ-
ences over the entire 449-bp fragment. For the
ompA gene, not only was there a considerable
number of nucleotide polymorphisms (e.g., there
were 52 nucleotide differences between alleles
1 and 2), but there was also a highly polymorphic
area of sequence that was 9 bp and 15 bp shorter
in alleles 2 and 4, respectively (see Fig. 3, which
compares the translated amino-acid sequences of
alleles 1 and 2). In the case of allele 4 (found in
sporadic isolate IR1), there was also an area of
sequence that was 3 bp longer than in the other
alleles; in addition, this allele had >80 nucleotide
differences with respect to both the Group 1 and 2
alleles. The blaOXA-51-like alleles 1, 2 and 3 corres-
ponded to blaOXA-66, blaOXA-69 and blaOXA-71,
respectively, over the 693 bp of sequence com-
pared (Table 4); any two of these alleles had 14–17
nucleotide differences from the other over this
sequence. Although many of the nucleotide chan-
ges were silent, a number of amino-acid changes
were apparent (Fig. 3; Table 4), which may have a
significant effect on the function of the proteins.
Although the nucleotide differences among the
Group 1 alleles at each locus were relatively small
(1–3 bases), these resulted, in the case of the csuE
and blaOXA-51-like genes, in amino-acid substitu-
tions (Table 4). Amino-acid substitutions among
most of the proteins of the various blaOXA-51-like
alleles found in this study have been compared
previously [27]. Sequence differences from
blaOXA-66 among Group 1 isolates (alleles 1a, 1a*
Table 3. Sequences of alleles at ompA, csuE and blaOXA-51-like
loci
Allele Sequence
1 39–724 of DQ648278 (686 bp)
1a As allele 1, but T instead of C
at nucleotide 638a (686 bp)
2 108–784 of DQ648279 (677 bp)
3 96–781 of DQ779967 (686 bp)
4 87–760 of DQ779966 (674 bp)
Allele Sequence
1 230–678 of DQ289018
1a 230–678 of DQ289019
1b As allele 1a, but T instead
of C at nucleotide 427b
2 230–678 of DQ289014
3 230–678 of DQ289016
4 6–454 of DQ789570
5 123–571 of DQ789571
6 99–547 of DQ789572
Allele Sequence Corresponds to
1 79–771 of AY750909 blaOXA-66
1a 79–771 of DQ309277 blaOXA-83
1a* As allele 1, but G instead
of C at nucleotide 499c
As blaOXA-66, but G instead
of C at nucleotide 499c
1b 79–771 of DQ309276 blaOXA-84
2 79–771 of AY750911 blaOXA-69
3 79–771 of AY750913 blaOXA-71
4 79–771 of AY750907 blaOXA-64
5 Shorter sequence only
determined corresponding
to 254–604 of DQ491200,
but A instead of T at
nucleotide 503c (351 bp)
As blaOXA-67, but A instead
of T at nucleotide 503c
aNumbering as in DQ648278.
bNumbering as in DQ289018.
cNumbering as in AJ309734, AY750909, DQ491200.
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and 1b) were associated in every case with the
presence of ISAba1 upstream of the gene (isolates
31J, SW1, Israel 21, 4I). These isolates had
blaOXA-51-like as the sole carbapenemase gene
and were meropenem-resistant (MIC >4 mg ⁄L).
Other representatives of the same genotypes,
but which did not have ISAba1 adjacent to the
bla-OXA-51-like gene, had the ‘standard’ allele 1
(corresponding to blaOXA-66) (isolates 16B, 4A, L5A)
and were meropenem-susceptible (MIC <4 mg ⁄L).
Sequence changes in blaOXA-51-like associated with
ISAba1 were consistent within a PFGE-defined
genotype, but varied among genotypes.
Group 1 isolates included all of the highly
successful genotypes currently found in the UK,
including the very widespread SE clone and OXA-
23 clone 1, and the representative of European
clone II. Group 2 isolates included the represent-
atives of European clone I and the French AYE
VEB-1 strain. The outbreak strains from the UK in
this group, known as OXA-23 clone 2, W strain
and BUAC-1, have affected far smaller numbers of
patients than those in Group 1 [1]. BUAC-1 has
been associated particularly with patients from
burns units. The Midlands 2 genotype (Group 3) is
a further relatively minor outbreak strain in the
UK [18,27]. Group 3 also included the representa-
tive of European clone III and outbreak strains
from hospitals in Spain and Israel.
Multiplex PCRs for identification of sequence
type groups
While sequencing is highly informative, it is not
readily available in all laboratories and is not
ideal for screening large numbers of isolates. The
1puorG
2puorG
3puorG
yrtnuoCselellAepytoneGetalosI
Fig. 1. Pulsed-field gel electrophoresis (PFGE) profiles of ApaI-digested genomic DNA and allele designations (in the order
ompA, csuE, blaOXA-51-like) for representative strains of Acinetobacter baumannii, including representatives of European clones
I–III. Strains belonging to the same sequence type group (Groups 1–3) clustered at a level of 69% (indicated by the broken
line) by PFGE with the parameters used. Circles, squares and diamonds indicate Groups 1, 2 and 3, respectively. Alleles
within the Group 1 clonal complex labelled 1a or 1b have one or two nucleotide difference(s), respectively, from allele 1. 1a*
indicates a distinct base-pair difference (G at nucleotide 499 of coding sequence) from allele 1a.
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substantial differences found in the sequences
described above presented the opportunity to
design primers to selectively amplify the alleles of
each group at these three loci, and thereby to
allow rapid identification of isolates belonging to
each of the outbreak groups.
All strains belonging to the Group 1 clonal
complex yielded all three fragments in the
Group 1 PCR, and none in the Group 2 PCR,
while strains belonging to Group 2 gave the
expected converse results (Fig. 4). Strains
belonging to Group 3 (ompA, csuE and blaOXA-
51-like alleles 2, 3 and 3), which share the same
ompA allele as Group 2, gave only the middle
fragment (for ompA) in the Group 2 PCR, but
gave the top two fragments (for the other two
loci) in the Group 1 PCR, despite some mismat-
ches between the primer sequences and these
Group 3 alleles. Outbreak strains can therefore
be readily assigned into these sequence types by
use of these multiplex PCRs, without any need
for sequencing. Nevertheless, sequencing re-
mains the best means of confirmation of the
results.
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Fig. 2. Dendrograms showing percentage similarity
between (a) csuE alleles (corresponding to nucleotides
230–678 of DQ648278) and (b) blaOXA-51-like alleles (corres-
ponding to nucleotides 79–771 of AJ309734) by pairwise
alignment. Circles, squares and diamonds indicate Group
1, 2 and 3 alleles, respectively.
Fig. 3. Partial amino-acid sequences translated from ompA
alleles 1 and 2 (corresponding to nuelotides 39–724 of
DQ648278 and nucleotides 108–784 of DQ648279, respect-
ively). Residues that differ are highlighted. For clarity, only
alleles 1 and 2 are compared here, but amino-acid
substitutions were also associated with alleles 3 and 4
(found in sporadic isolates L4 and IR1), available under
accession numbers DQ779967 and DQ779966.
Table 4. Amino-acid differences in the proteins encoded
by the blaOXA-51-like and csuE genes for the sequences
determined
Allele
Corresponding
toa
Amino-acid at residue
36 57 96 101 107 117 129 130 167 168 225
1 OXA-66 V Q A V K D I P L V N
1a OXA-83 V Q A V K D L P L V N
1a* Not assigned V Q A V K D I P V V N
1b OXA-84 V Q A V K D I S L A N
2 OXA-69 D H A V E N I P L V N
3 OXA-71 E Q T V Q D I P L V D
4 OXA-64 E Q A V Q D I P L V D
5 Not assignedb NDc ND A I Q D I P L E ND
Allele
Amino-acid at residue
133 149 172 180 183
1 F Q V R A
1a Y Q V R A
1b Y Q V R V
2 F R A K V
3 F R A K V
4 F R A K V
5 F Q V R A
6 F R A K V
19606d F Q V R A
aRefers only to nucleotides 79–771. Complete coding sequences were determined
for some isolates (1 (allele 2), 4A, 16B (allele 1), 4I (allele 1b) and 31J (allele 1a)), and
did match the relevant blaOXA gene over the entire 825 bp [27].
bSequence corresponding to nucleotides 254–604 only was determined. This differs
from blaOXA-67 by one base (A at nucleotide 503) over the sequence determined.
cND, not determined.
dData on type strain ATCC 19606 obtained from GenBank accession number
AY241696.
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DISCUSSION
The isolates investigated in this study were from
five different countries and represented a number
of distinct PFGE types. The genes studied had
high numbers of polymorphisms, but all of the
outbreak strains belonged to one of three, highly
distinct, sequence type groups. These data sug-
gest that these outbreak isolates consist of three
distinct lineages, and that outbreak strains
of A. baumannii are highly clonal, with a low
frequency of recombination [32]. In such popula-
tions, relatively few overall sequence types are
seen, as was the case in the present study.
Diversity may be caused by movement of inser-
tion sequences [32], a feature already recognised
as being important in A. baumannii [27,33–35]. The
clonal lineages identified were found to corres-
pond to pan-European clones I, II and III, defined
by amplified fragment length polymorphism ana-
lysis (Group 1 corresponding to European clone
II, Group 2 to European clone I, and Group 3
to European clone III), thus providing further
evidence to support the original descriptions of
these lineages [16,17]. Isolates can be assigned to
these lineages with absolute certainty by sequence
typing, while amplified fragment length poly-
morphism analysis may provide more ambiguous
results.
These sequence types were present in multiple
and distant locations, and may arise in different
hospitals through a combination of independent
selection from very widespread common ances-
tors and some degree of spread, perhaps
facilitated by patient transfers [16]. Perhaps ‘out-
break’ may not be the most appropriate term to
apply to these strains, since their persistence may
be a result, at least in part, of their continual
selection in hospitals under antibiotic pressure,
rather than a true outbreak situation. This may
explain their repeated reappearance in hospitals,
despite the best efforts of staff to eradicate them.
All of the highly successful genotypes defined
in the UK by PFGE were found to belong to
sequence type Group 1 (European clone II). This
group may represent a particularly successful
lineage, accounting for the increased prevalence
of this organism in hospitals in recent years.
Similarly, the most prevalent genotypes from the
Israeli hospital (Israel A and B, in that order) were
1 2 3 4 5 6 7 8 9 M 10 11 12 M 13
1 2 3 4 5 6 7 8 9 M 10 11 12 M 13
Group 1 PCR(a)
(b) Group 2 PCR
123
369
369
246
246
123
Group 1 isolates Group 2
isolates
Group 3
isolates
Group 1 isolates Group 2 
isolates
Group 3 
isolates
bp
bp
615
861
615
861
ompA
csuE
blaOXA-51-
like
ompA
csuE
blaOXA-51-
like
Fig. 4. Examples of multiplex PCRs
designed to selectively amplify
ompA, csuE and blaOXA-51-like alleles
of isolates belonging to (a) Group 1
and (b) Group 2. Genotypes and
country of isolation were: lanes 1–6
(Group 1), Strain A (Israel), SE clone,
24AC-1, NW strain (UK), clone II
(Spain), T strain (UK); lanes 7–9
(Group 2), AYE VEB-1 (France),
OXA-23 clone 2, W strain (UK);
lanes 10–12 (Group 3), Midlands 2
(UK), clone I, clone I (Spain). Strains
in lanes 1, 3, 4, 5, 6, 7, 9, 10, 11 and 12
were Israel 1, 24, 33, 5 ⁄ 28, 4A, AYE
VEB-1, 1, 4C, 5 ⁄ 5 and 9 ⁄ 46, respect-
ively. Lanes labelled M contain a
123-bp size ladder; a negative
(water) control is contained in lane
13.
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both representatives of Group 1. Ikonomidis et al.
[36] reported a predominance of blaOXA-66 among
Greek isolates of A. baumannii; as blaOXA-66 is the
blaOXA-51-like allele of Group 1 isolates (allele 1),
this indicates that Group 1 genotypes are also
predominant in Greece. However, in some coun-
tries, outbreak strains of the other sequence type
groups appear to be more important. Thus, the
AYE VEB-1 strain, which has affected large
numbers of hospitals in France, belongs to
Group 2. In the Spanish hospital from which the
isolates of clone I (Group 3) and clone II (Group 1)
were obtained, clone I is currently the most
prevalent; both have blaOXA-40 as an additional
carbapenemase gene [5].
The stability of these sequence types is remark-
able; RUH 875 and RUH 2034 were isolated some
20 years before other representatives of Group 2,
yet their sequences at the loci examined are
identical. Similarly, Huys et al. [21] found that
adeB sequences in representatives of European
clones I, II and III were distinct from each other,
but identical within a clone, despite representa-
tives having been isolated from different coun-
tries at intervals of up to 20 years.
PFGE clearly divided the outbreak strains into
clusters that agreed with the sequence type
groupings (Fig. 1), and also gave greater dis-
crimination than that obtained by sequence-
based typing. The so-called ‘micro-variation’
revealed by PFGE profiles, coupled with any
extra information obtained from integron analy-
sis and detection of additional genes such as
blaOXA-23-like genes, is helpful in investigating
individual outbreaks of this highly clonal spe-
cies. Perhaps true outbreaks can only be inferred
on the basis of identical or near-identical PFGE
profiles, which are most consistent with spread.
Even then, a situation could be envisaged in
which parallel selection under similar pressures
may result in highly similar strains. It is note-
worthy that the PFGE profiles of some isolates in
this study, such as Israel 28 and RUH 5875, were
very similar, although they originated from
different countries.
The group-specific PCRs facilitated rapid iden-
tification of the sequence type group or clonal
lineage of outbreak strains, without any need for
sequencing or other typing techniques, thereby
bringing such analysis within the scope of a wide
range of users. This approach may prove helpful
in identifying the genotypes that are most likely
to cause problems in hospitals. In the UK, geno-
types belonging to sequence type Group 1 are, by
far, the most successful. Investigation of differ-
ences in the structure and function of the proteins
encoded by the alleles of the three outbreak
groups could provide insights into their relative
pathogenicity and success.
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